Overview

  • Product nameAnti-SUMF1 antibody
    See all SUMF1 primary antibodies
  • Description
    Goat polyclonal to SUMF1
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Cow, Dog
  • Immunogen

    Synthetic peptide:

    C-ETLNPKGPPSGKDR

    , corresponding to internal sequence amino acids 314-327 of Human SUMF1 (NP_877437.2).

  • Positive control
    • Mouse pancreas, Mouse eye and Human kidney lysates

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • Purification notesab91479 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Associated products

Applications

Our Abpromise guarantee covers the use of ab91479 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 37 kDa (predicted molecular weight: 40 kDa).


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionUsing molecular oxygen and an unidentified reducing agent, oxidizes a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also called C(alpha)-formylglycine. Known substrates include GALNS, ARSA, STS and ARSE.
    • Tissue specificityUbiquitous. Highly expressed in kidney, pancreas and liver. Detected at lower levels in leukocytes, lung, placenta, small intestine, skeletal muscle and heart.
    • PathwayProtein modification; sulfatase oxidation.
    • Involvement in diseaseDefects in SUMF1 are the cause of multiple sulfatase deficiency (MSD) [MIM:272200]. MSD is a clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Inheritance is autosomal recessive.
    • Sequence similaritiesBelongs to the sulfatase-modifying factor family.
    • Post-translational
      modifications
      N-glycosylated. Contains high-mannose-type oligosaccharides.
    • Cellular localizationEndoplasmic reticulum lumen.
    • Information by UniProt
    • Database links
    • Alternative names
      • MGC150436 antibody
      • AAPA3037 antibody
      • C alpha formylglycine generating enzyme 1 antibody
      • C-alpha-formylglycine-generating enzyme 1 antibody
      • FGE antibody
      • FGly generating enzyme antibody
      • MGC131853 antibody
      • Sulfatase modifying factor 1 [Precursor] antibody
      • Sulfatase-modifying factor 1 antibody
      • SUMF1 antibody
      • SUMF1_HUMAN antibody
      • UNQ3037 antibody
      see all

    Anti-SUMF1 antibody images

    References for Anti-SUMF1 antibody (ab91479)

    ab91479 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab91479.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"